Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 236

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Role of corticotropin releasing factor in anxiety disorders: A translational research perspective

Open access
Risbrough, Victoria B., Stein, Murray B.·2006·Hormones and Behavior

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yhbeh.2006.06.019

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 164

  1. Abduljawad, 2001, Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man, J. Psychopharmacol., 15, 237, 10.1177/026988110101500402 · DOI
  2. Abelson, 1996, Hypothalamic–pituitary–adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol, Arch. Gen. Psychiatry, 53, 323, 10.1001/archpsyc.1996.01830040059010 · DOI
  3. Abelson, 2005, Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects, Arch. Gen. Psychiatry, 62, 668, 10.1001/archpsyc.62.6.668 · DOI
  4. Altemus, 1992, Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive compulsive disorder, Arch. Gen. Psychiatry, 49, 9, 10.1001/archpsyc.1992.01820010009002 · DOI · Paper page
  5. Baker, 1999, Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder, Am. J. Psychiatry, 156, 585, 10.1176/ajp.156.4.585 · DOI · Paper page
  6. Baker, D.G., Risbrough, V.B., Schork, N.J., in press. Posttraumatic stress disorder: genetic and environmental risk factors. Biobehavioral Resilience to Stress, State of the Art Report. U.S. Dept. of Defense.
  7. Bakshi, 2000, Corticotropin-releasing hormone and animal models of anxiety: gene–environment interactions, Biol. Psychiatry, 48, 1175, 10.1016/S0006-3223(00)01082-9 · DOI
  8. Bakshi, 2002, Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala, J. Neurosci., 22, 2926, 10.1523/JNEUROSCI.22-07-02926.2002 · DOI · Paper page
  9. Bale, 2003, Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses, J. Neurosci., 23, 5295, 10.1523/JNEUROSCI.23-12-05295.2003 · DOI · Paper page
  10. Bale, 2000, Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress, Nat. Genet., 24, 410, 10.1038/74263 · DOI · Paper page
  11. Bale, 2002, Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior, J. Neurosci., 22, 193, 10.1523/JNEUROSCI.22-01-00193.2002 · DOI · Paper page
  12. Banki, 1992, Cerebrospinal fluid neuropeptides in mood disorder and dementia, J. Affect. Disord., 25, 39, 10.1016/0165-0327(92)90091-J · DOI
  13. Bartz, 2006, Is obsessive-compulsive disorder an anxiety disorder?, Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 338, 10.1016/j.pnpbp.2005.11.003 · DOI · Paper page
  14. Bassett, 1992, Distribution of corticotropin-releasing factor-like immunoreactivity in squirrel monkey (Saimiri sciureus) amygdala, J. Comp. Neurol., 323, 91, 10.1002/cne.903230108 · DOI
  15. Bassett, 1992, Localization of corticotropin-releasing factor-like immunoreactivity in monkey olfactory bulb and secondary olfactory areas, J. Comp. Neurol., 316, 348, 10.1002/cne.903160306 · DOI
  16. Behan, 1995, Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides, Front. Neuroendocrinol., 16, 362, 10.1006/frne.1995.1013 · DOI · Paper page
  17. Bissette, 2003, Elevated concentrations of CRF in the locus coeruleus of depressed subjects, Neuropsychopharmacology, 28, 1328, 10.1038/sj.npp.1300191 · DOI · Paper page
  18. Bracha, 2005, Postmortem locus coeruleus neuron count in three American veterans with probable or possible war-related PTSD, J. Neuropsychiatry Clin. Neurosci., 17, 503, 10.1176/appi.neuropsych.17.4.503 · DOI
  19. Braff, 2001, Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies, Psychopharmacology (Berlin), 156, 234, 10.1007/s002130100810 · DOI · Paper page
  20. Brake, 2000, Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex, Neuroscience, 96, 687, 10.1016/S0306-4522(00)00002-6 · DOI
  21. Buchanan, 2001, Exogenous cortisol exerts effects on the startle reflex independent of emotional modulation, Pharmacol. Biochem. Behav., 68, 203, 10.1016/S0091-3057(00)00450-0 · DOI
  22. Butler, 1990, Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD, Am. J. Psychiatry, 147, 1308, 10.1176/ajp.147.10.1308 · DOI · Paper page
  23. Chappell, 1996, Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls, Biol. Psychiatry, 39, 776, 10.1016/0006-3223(95)00221-9 · DOI
  24. Charney, 2004, Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress, Am. J. Psychiatry, 161, 195, 10.1176/appi.ajp.161.2.195 · DOI · Paper page
  25. Chen, 1993, Expression cloning of a human corticotropin-releasing-factor receptor, Proc. Natl. Acad. Sci. U. S. A., 90, 8967, 10.1073/pnas.90.19.8967 · DOI · Paper page
  26. Claes, 2003, The corticotropin-releasing hormone binding protein is associated with major depression in a population from Northern Sweden, Biol. Psychiatry, 54, 867, 10.1016/S0006-3223(03)00425-6 · DOI
  27. Cohen, 2006, Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats, Biol. Psychiatry., 59, 1208, 10.1016/j.biopsych.2005.12.003 · DOI · Paper page
  28. Conti, 2005, Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar–Kyoto rats, Eur. J. Pharmacol., 507, 125, 10.1016/j.ejphar.2004.11.055 · DOI
  29. Conti, 2002, Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains, Psychopharmacology (Berlin), 161, 296, 10.1007/s00213-002-1025-2 · DOI
  30. Coste, 2000, Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2, Nat. Genet., 24, 403, 10.1038/74255 · DOI · Paper page
  31. Coste, 2001, Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress, Peptides, 22, 733, 10.1016/S0196-9781(01)00386-2 · DOI
  32. Coste, 2006, Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress, Genes Brain Behav., 5, 131, 10.1111/j.1601-183X.2005.00142.x · DOI
  33. Dautzenberg, 2002, The CRF peptide family and their receptors: yet more partners discovered, Trends Pharmacol. Sci., 23, 71, 10.1016/S0165-6147(02)01946-6 · DOI · Paper page
  34. Davis, 1998, Are different parts of the extended amygdala involved in fear versus anxiety?, Biol. Psychiatry, 44, 1239, 10.1016/S0006-3223(98)00288-1 · DOI · Paper page
  35. Davis, 1969, Habituation of startle response under incremental sequence of stimulus intensities, J. Comp. Physiol. Psychol., 67, 486, 10.1037/h0027308 · DOI
  36. Davis, 1993, Fear-potentiated startle: a neural and pharmacological analysis, Behav. Brain Res., 58, 175, 10.1016/0166-4328(93)90102-V · DOI · Paper page
  37. Davis, 1997, Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex, Philos. Trans. R. Soc. London, Ser. B Biol. Sci., 352, 1675, 10.1098/rstb.1997.0149 · DOI · Paper page
  38. De Souza, 1995, Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders, Psychoneuroendocrinology, 20, 789, 10.1016/0306-4530(95)00011-9 · DOI · Paper page
  39. Deussing, 2005, Dissecting the genetic effect of the CRH system on anxiety and stress-related behaviour, C. R., Biol., 328, 199, 10.1016/j.crvi.2005.01.001 · DOI
  40. Dirks, 2002, Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone, Biol. Psychiatry, 51, 583, 10.1016/S0006-3223(01)01323-3 · DOI
  41. Dirks, 2003, Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs, Neuropsychopharmacology, 28, 1790, 10.1038/sj.npp.1300256 · DOI
  42. Dyck, 2005, Potent, orally active corticotropin-releasing factor receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine core, J. Med. Chem., 48, 4100, 10.1021/jm050070m · DOI
  43. Eckart, 2002, Pharmacology and biology of corticotropin-releasing factor (CRF) receptors, Recept. Channels, 8, 163, 10.1080/10606820213678 · DOI
  44. Faraday, 2002, Rat sex and strain differences in responses to stress, Physiol. Behav., 75, 507, 10.1016/S0031-9384(02)00645-5 · DOI · Paper page
  45. Foote, 1988, Distribution of corticotropin-releasing-factor-like immunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): an immunohistochemical study, J. Comp. Neurol., 276, 239, 10.1002/cne.902760208 · DOI
  46. Fossey, 1996, Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects, Biol. Psychiatry, 39, 703, 10.1016/0006-3223(95)00197-2 · DOI · Paper page
  47. Fullana, 2005, Influence of individual differences in Behavioral Inhibition System on the magnitude and time course of the fear-potentiated startle, Int. J. Psychophysiol.
  48. Geracioti, 1992, Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans, J. Clin. Endocrinol. Metab., 74, 1325, 10.1210/jc.74.6.1325 · doi:10.1210/jc.74.6.1325
  49. Geracioti, 1997, Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression, Biol. Psychiatry, 42, 165, 10.1016/S0006-3223(96)00312-5 · DOI
  50. Geyer, 1987, Startle habituation and sensorimotor gating in schizophrenia and related animal models, Schizophr. Bull., 13, 643, 10.1093/schbul/13.4.643 · DOI · Paper page
  51. Gillette, 1997, Combat veterans with posttraumatic stress disorder exhibit decreased habituation of the P1 midlatency auditory evoked potential, Life Sci., 61, 1421, 10.1016/S0024-3205(97)00688-7 · DOI
  52. Goozen, 2004, Evidence of fearlessness in behaviourally disordered children: a study on startle reflex modulation, J. Child Psychol. Psychiatry, 45, 884, 10.1111/j.1469-7610.2004.00280.x · DOI
  53. Graham, 1975, Presidential Address, 1974. The more or less startling effects of weak prestimulation, Psychophysiology, 12, 238, 10.1111/j.1469-8986.1975.tb01284.x · DOI · Paper page
  54. Grigoriadis, 2005, The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders, Expert Opin. Ther. Targets, 9, 651, 10.1517/14728222.9.4.651 · DOI
  55. Grillon, 2003, A review of the modulation of the startle reflex by affective states and its application in psychiatry, Clin. Neurophysiol., 114, 1557, 10.1016/S1388-2457(03)00202-5 · DOI · Paper page
  56. Grillon, 1999, Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder, J. Abnorm. Psychol., 108, 134, 10.1037/0021-843X.108.1.134 · DOI · Paper page
  57. Grillon, 1997, Startle modulation in children at risk for anxiety disorders and/or alcoholism, J. Am. Acad. Child Adolesc. Psych., 36, 925, 10.1097/00004583-199707000-00014 · DOI · Paper page
  58. Grillon, 1998, Fear-potentiated startle in adolescent offspring of parents with anxiety disorders, Biol. Psychiatry, 44, 990, 10.1016/S0006-3223(98)00188-7 · DOI
  59. Grillon, 1998, Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder, Biol. Psychiatry, 44, 1027, 10.1016/S0006-3223(98)00034-1 · DOI · Paper page
  60. Grillon, 2005, Cortisol and DHEA-S are associated with startle potentiation during aversive conditioning in humans, Psychopharmacology, 186, 434, 10.1007/s00213-005-0124-2 · DOI
  61. Grillon, 2005, Families at high and low risk for depression: a three-generation startle study, Biological. Psychiatry, 57, 953, 10.1016/j.biopsych.2005.01.045 · DOI · Paper page
  62. Guthrie, 2005, Auditory startle response in firefighters before and after trauma exposure, Am. J. Psychiatry, 162, 283, 10.1176/appi.ajp.162.2.283 · DOI
  63. Gutman, 2003, The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress, J. Pharmacol. Exp. Ther., 304, 874, 10.1124/jpet.102.042788 · DOI
  64. Habib, 2000, Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates, Proc. Natl. Acad. Sci. U. S. A., 97, 6079, 10.1073/pnas.97.11.6079 · DOI · Paper page
  65. Hammack, 2002, The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress, J. Neurosci., 22, 1020, 10.1523/JNEUROSCI.22-03-01020.2002 · DOI · Paper page
  66. Hammack, 2003, Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress, Behav. Brain Res., 147, 55, 10.1016/S0166-4328(03)00133-5 · DOI
  67. Hammack, 2003, Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress, J. Neurosci., 23, 1019, 10.1523/JNEUROSCI.23-03-01019.2003 · DOI · Paper page
  68. Hasler, 2004, Discovering endophenotypes for major depression, Neuropsychopharmacology, 10.1038/sj.npp.1300506 · DOI · Paper page
  69. Hauger, R.L., Risbrough, V.B., Brauns, O., Dautyenberg, F.M., in press. Corticotropin releasing factor receptor signaling in the central nervous system: new molecular targets. Current Drug Targets.
  70. Hawk, 2003, Affective modulation and prepulse inhibition of startle among undergraduates high and low in behavioral inhibition and approach, Psychophysiology, 40, 131, 10.1111/1469-8986.00013 · DOI
  71. Heinrichs, 2002, Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist, Neuropsychopharmacology, 27, 194, 10.1016/S0893-133X(02)00299-3 · DOI
  72. Heldt, 2000, Posttraining lesions of the amygdala interfere with fear-potentiated startle to both visual and auditory conditioned stimuli in C57BL/6J mice, Behav. Neurosci., 114, 749, 10.1037/0735-7044.114.4.749 · DOI
  73. Heuser, 1998, Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment, Depress. Anxiety, 8, 71, 10.1002/(SICI)1520-6394(1998)8:2<71::AID-DA5>3.0.CO;2-N · DOI · Paper page
  74. Ho, 2001, Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor, Brain Res. Mol. Brain Res., 89, 29, 10.1016/S0169-328X(01)00050-X · DOI
  75. Hoffman, 1980, Reflex modification in the domain of startle: I: Some empirical findings and their implications for how the nervous system processes sensory input, Psychol. Rev., 87, 175, 10.1037/0033-295X.87.2.175 · doi:10.1037/0033-295x.87.2.175 · Paper page
  76. Hucks, 1997, Corticotropin-releasing factor binding sites in cortex of depressed suicides, Psychopharmacology (Berlin), 134, 174, 10.1007/s002130050439 · DOI
  77. Hull, 2002, Neuroimaging findings in post-traumatic stress disorder. Systematic review, Br. J. Psychiatry, 181, 102, 10.1017/S000712500016180X · DOI
  78. Jolkkonen, 1993, CSF corticotropin-releasing factor is not affected in panic disorder, Biol. Psychiatry, 33, 136, 10.1016/0006-3223(93)90315-5 · DOI · Paper page
  79. Kaviani, 2004, Affective modulation of the startle response in depression: influence of the severity of depression, anhedonia, and anxiety, J. Affect. Disord., 83, 21, 10.1016/j.jad.2004.04.007 · DOI · Paper page
  80. Kellner, 2004, Metyrapone tests in patients with panic disorder, Biol. Psychiatry, 56, 898, 10.1016/j.biopsych.2004.08.005 · doi:10.1016/j.biopsych.2004.08.005
  81. Kishimoto, 2000, Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2, Nat. Genet., 24, 415, 10.1038/74271 · DOI · Paper page
  82. Klorman, 2003, Acoustic startle in maltreated children, J. Abnorm. Child Psychol., 31, 359, 10.1023/A:1023835417070 · DOI
  83. Koob, 1999, Corticotropin-releasing factor, norepinephrine, and stress, Biol. Psychiatry, 46, 1167, 10.1016/S0006-3223(99)00164-X · DOI · Paper page
  84. Kostich, 1998, Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor, Mol. Endocrinol., 12, 1077, 10.1210/me.12.8.1077 · DOI
  85. Kostich, 2004, Immunohistochemical visualization of corticotropin-releasing factor type 1 (CRF1) receptors in monkey brain, J. Comp. Neurol., 478, 111, 10.1002/cne.20271 · DOI
  86. Kumari, 2003, Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects, Psychiatry Res. Neuroimaging, 122, 99, 10.1016/S0925-4927(02)00123-3 · DOI · Paper page
  87. Lang, 1995, The emotion probe. Studies of motivation and attention, Am. Psychol., 50, 372, 10.1037/0003-066X.50.5.372 · DOI · Paper page
  88. Lavicky, 1993, Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis, J. Neurochem., 60, 602, 10.1111/j.1471-4159.1993.tb03191.x · DOI · Paper page
  89. Le, 2002, The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol, J. Neurosci., 22, 7844, 10.1523/JNEUROSCI.22-18-07844.2002 · DOI
  90. Leake, 1990, Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression, Biol. Psychiatry, 28, 603, 10.1016/0006-3223(90)90398-L · DOI
  91. Lee, 1997, Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex, J. Neurosci., 17, 6434, 10.1523/JNEUROSCI.17-16-06434.1997 · DOI · Paper page
  92. Lee, 1994, Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF), Brain Res., 666, 93, 10.1016/0006-8993(94)90286-0 · DOI
  93. Lewis, 1989, Corticotropin-releasing factor immunoreactivity in monkey neocortex: an immunohistochemical analysis, J. Comp. Neurol., 290, 599, 10.1002/cne.902900412 · DOI
  94. Liaw, 1996, Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid, Endocrinology, 137, 72, 10.1210/en.137.1.72 · DOI · Paper page
  95. Liu, 2004, Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission, J. Neurosci., 24, 4020, 10.1523/JNEUROSCI.5531-03.2004 · DOI
  96. Lorberbaum, 2004, Neural correlates of speech anticipatory anxiety in generalized social phobia, NeuroReport, 15, 2701
  97. Lovenberg, 1995, Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain, Proc. Natl. Acad. Sci. U. S. A., 92, 836, 10.1073/pnas.92.3.836 · DOI · Paper page
  98. Ludewig, 2003, No prepulse inhibition deficits in patients with unipolar depression, Depress. Anxiety, 17, 224, 10.1002/da.10109 · DOI
  99. Ludewig, 2005, Information-processing deficits and cognitive dysfunction in panic disorder, J. Psychiatry Neurosci., 30, 37
  100. Makino, 1994, Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus, Brain Res., 657, 141, 10.1016/0006-8993(94)90961-X · DOI · Paper page
  101. McKenna, 2005, Assessing the burden of disease in the United States using disability-adjusted life years, Am. J. Prev. Med., 28, 415, 10.1016/j.amepre.2005.02.009 · DOI · Paper page
  102. Medina, 2001, Startle reactivity and PTSD symptoms in a community sample of women, Psychiatry Res., 101, 157, 10.1016/S0165-1781(01)00221-9 · DOI
  103. Merali, 2004, Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABAA receptor subunits in frontal cortical brain region, J. Neurosci., 24, 1478, 10.1523/JNEUROSCI.4734-03.2004 · DOI · Paper page
  104. Metzger, 1999, Physiologic reactivity to startling tones in women with posttraumatic stress disorder, J. Abnorm. Psychol., 108, 347, 10.1037/0021-843X.108.2.347 · doi:10.1037/0021-843x.108.2.347
  105. Morgan, 1996, Exaggerated acoustic startle reflex in Gulf War veterans with posttraumatic stress disorder, Am. J. Psychiatry, 153, 64, 10.1176/ajp.153.1.64 · DOI · Paper page
  106. Murray, 1997, Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study, Lancet, 349, 1498, 10.1016/S0140-6736(96)07492-2 · DOI · Paper page
  107. Nair, 2005, Central oxytocin, vasopressin, and corticotropin-releasing factor receptor densities in the basal forebrain predict isolation potentiated startle in rats, J. Neurosci., 25, 11479, 10.1523/JNEUROSCI.2524-05.2005 · DOI
  108. Nemeroff, 1998, Psychopharmacology of affective disorders in the 21st century, Biol. Psychiatry, 44, 517
  109. Nemeroff, 1988, Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims, Arch. Gen. Psychiatry, 45, 577, 10.1001/archpsyc.1988.01800300075009 · DOI · Paper page
  110. Nemeroff, 1991, Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin, Br. J. Psychiatry, 158, 59, 10.1192/bjp.158.1.59 · DOI · Paper page
  111. Neumeister, 2004, Reduced serotonin type 1A receptor binding in panic disorder, J. Neurosci., 24, 589, 10.1523/JNEUROSCI.4921-03.2004 · DOI · Paper page
  112. Nitschke, 2002, Startle potentiation in aversive anticipation: evidence for state but not trait effects, Psychophysiology, 39, 254, 10.1111/1469-8986.3920254 · doi:10.1111/1469-8986.3920254
  113. Norris, 1996, A relationship between inhibition of the acoustic startle response and the protection of prepulse processing, Psychobiology, 24, 160, 10.3758/BF03331968 · DOI
  114. Ornitz, 1989, Startle modulation in children with posttraumatic stress disorder, Am. J. Psychiatry, 146, 866, 10.1176/ajp.146.7.866 · DOI · Paper page
  115. Orr, 1995, Physiologic responses to loud tones in Vietnam veterans with posttraumatic stress disorder, J. Abnorm. Psychol., 104, 75, 10.1037/0021-843X.104.1.75 · doi:10.1037/0021-843x.104.1.75 · Paper page
  116. Osuch, 2004, Brain environment interactions: stress, posttraumatic stress disorder, and the need for a postmortem brain collection, Psychiatry, 67, 353, 10.1521/psyc.67.4.353.56565 · DOI
  117. Pecoraro, 2005, Glucocorticoids dose-dependently remodel energy stores and amplify incentive relativity effects, Psychoneuroendocrinology, 30, 815, 10.1016/j.psyneuen.2005.03.010 · DOI
  118. Peri, 2000, Psychophysiologic assessment of aversive conditioning in posttraumatic stress disorder, Biol. Psychiatry, 47, 512, 10.1016/S0006-3223(99)00144-4 · DOI · Paper page
  119. Perrin, 1993, Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor, Endocrinology, 133, 3058, 10.1210/en.133.6.3058 · doi:10.1210/en.133.6.3058 · Paper page
  120. Perry, 2004, Prepulse inhibition in patients with non-psychotic major depressive disorder, J. Affect. Disord., 81, 179, 10.1016/S0165-0327(03)00157-5 · DOI
  121. Price, 2001, Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor, J. Neurosci., 21, 2833, 10.1523/JNEUROSCI.21-08-02833.2001 · DOI · Paper page
  122. Quednow, 2006, Normal prepulse inhibition and habituation of acoustic startle response in suicidal depressive patients without psychotic symptoms, J. Affective Disord., 92, 299, 10.1016/j.jad.2006.01.022 · DOI
  123. Raadsheer, 1994, Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients, Neuroendocrinology, 60, 436, 10.1159/000126778 · DOI · Paper page
  124. Raadsheer, 1995, Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression, Am. J. Psychiatry, 152, 1372, 10.1176/ajp.152.9.1372 · DOI · Paper page
  125. Radant, 2001, Biological markers and diagnostic accuracy in the genetics of posttraumatic stress disorder, Psychiatry Res., 102, 203, 10.1016/S0165-1781(01)00252-9 · DOI
  126. Radulovic, 2000, Role of regional neurotransmitter receptors in corticotropin-releasing factor (CRF)-mediated modulation of fear conditioning, Neuropharmacology, 39, 707, 10.1016/S0028-3908(99)00185-9 · DOI
  127. Rattiner, 2004, Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning, J. Neurosci., 24, 4796, 10.1523/JNEUROSCI.5654-03.2004 · DOI · Paper page
  128. Reul, 2002, Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression, Curr. Opin. Pharmacol., 2, 23, 10.1016/S1471-4892(01)00117-5 · DOI · Paper page
  129. Risbrough, 2005, Anxiogenic treatments do not increase fear-potentiated startle in mice, Biol. Psychiatry, 57, 33, 10.1016/j.biopsych.2004.10.006 · DOI
  130. Risbrough, 2003, GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice, Neuropsychopharmacology, 28, 654, 10.1038/sj.npp.1300079 · DOI
  131. Risbrough, 2003, Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice, Psychopharmacology (Berlin), 170, 178, 10.1007/s00213-003-1535-6 · DOI
  132. Risbrough, 2004, Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior, J. Neurosci., 24, 6545, 10.1523/JNEUROSCI.5760-03.2004 · DOI
  133. Roozendaal, 2002, Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation, Proc. Natl. Acad. Sci., 99, 13908, 10.1073/pnas.212504599 · DOI · Paper page
  134. Sananbenesi, 2003, Mitogen-activated protein kinase signaling in the hippocampus and its modulation by corticotropin-releasing factor receptor 2: a possible link between stress and fear memory, J. Neurosci., 23, 11436, 10.1523/JNEUROSCI.23-36-11436.2003 · DOI
  135. Sanchez, 1999, Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain, J. Comp. Neurol., 408, 365, 10.1002/(SICI)1096-9861(19990607)408:3<365::AID-CNE5>3.0.CO;2-N · DOI
  136. Sanchez, 2005, Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing, Biol. Psychiatry, 57, 373, 10.1016/j.biopsych.2004.11.032 · DOI · Paper page
  137. Schneider, 1999, Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia, Biol. Psychiatry, 45, 863, 10.1016/S0006-3223(98)00269-8 · DOI · Paper page
  138. Schulkin, 2005, A neuroendocrine mechanism for sustaining fear, Trends Neurosci., 28, 629, 10.1016/j.tins.2005.09.009 · DOI · Paper page
  139. Schulz, 1996, CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors, Proc. Natl. Acad. Sci. U. S. A., 93, 10477, 10.1073/pnas.93.19.10477 · DOI · Paper page
  140. Shalev, 2000, Auditory startle response in trauma survivors with posttraumatic stress disorder: a prospective study, Am. J. Psychiatry, 157, 255, 10.1176/appi.ajp.157.2.255 · DOI · Paper page
  141. Shekhar, 2005, Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety, Stress, 8, 209, 10.1080/10253890500504557 · DOI · Paper page
  142. Sipos, 2000, Behavioral effects Of 8-OH-DPAT in chronically stressed male and female rats, Pharmacol. Biochem. Behav., 66, 403, 10.1016/S0091-3057(00)00178-7 · DOI
  143. Skinner, 1999, Reduced sensory gating of the P1 potential in rape victims and combat veterans with posttraumatic stress disorder, Depress. Anxiety, 9, 122, 10.1002/(SICI)1520-6394(1999)9:3<122::AID-DA4>3.0.CO;2-M · DOI
  144. Smoller, 2003, Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition, Biol. Psychiatry, 54, 1376, 10.1016/S0006-3223(03)00598-5 · DOI
  145. Smoller, 2005, The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder, Biol. Psychiatry, 57, 1485, 10.1016/j.biopsych.2005.02.018 · DOI · Paper page
  146. Soravia, 2006, Glucocorticoids reduce phobic fear in humans, Proc. Natl. Acad. Sci. U. S. A., 10.1073/pnas.0509184103 · DOI · Paper page
  147. Spina, 1996, Appetite-suppressing effects of urocortin, a CRF-related neuropeptide, Science, 273, 1561, 10.1126/science.273.5281.1561 · DOI · Paper page
  148. Swerdlow, 1989, Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9–41), Neuropsychopharmacology, 2, 285, 10.1016/0893-133X(89)90033-X · DOI · Paper page
  149. Swerdlow, 1999, Effects of discrete acoustic prestimuli on perceived intensity and behavioral responses to startling acoustic and tactile stimuli, Psychobiology, 27, 54, 10.3758/BF03332152 · DOI
  150. Swerdlow, 2001, Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges, Psychopharmacology (Berlin), 156, 194, 10.1007/s002130100799 · DOI · Paper page
  151. Valdez, 2005, Homeostasis within the corticotropin-releasing factor system via CRF2 receptor activation: a novel approach for the treatment of anxiety, Drug Dev. Res., 65, 205, 10.1002/ddr.20024 · DOI
  152. Valentino, 2005, Peptides that fine-tune the serotonin system, Neuropeptides, 39, 1, 10.1016/j.npep.2004.09.005 · DOI
  153. Van Den Eede, 2005, Corticotropin-releasing factor-binding protein, stress and major depression, Ageing Res. Rev., 4, 213, 10.1016/j.arr.2005.02.002 · DOI
  154. Van Pett, 2000, Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse, J. Comp. Neurol., 428, 191, 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U · DOI · Paper page
  155. Waddell, J., Falls, W., 2003. Corticotropin – releasing hormone (CRF) antagonist alpha – helical CRF blocks reinstatement of extinguished conditioned fear. In P. N. 538.6 (Ed.), Abstract reviewer/Itinerary Planner. Society for Neuroscience, Washington D.C.
  156. Walker, 2002, The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction, Pharmacol. Biochem. Behav., 71, 379, 10.1016/S0091-3057(01)00698-0 · DOI · Paper page
  157. Weike, 2005, Fear conditioning following unilateral temporal lobectomy: dissociation of conditioned startle potentiation and autonomic learning, J. Neurosci., 25, 11117, 10.1523/JNEUROSCI.2032-05.2005 · DOI · Paper page
  158. Wessa, 2005, Central and peripheral psychophysiological responses to trauma-related cues in subclinical posttraumatic stress disorder: a pilot study, Exp. Brain Res., 167, 56, 10.1007/s00221-005-0007-0 · DOI
  159. Yang, 2006, Systemic and intra-amygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear, Neuropsychopharmacology, 31, 912, 10.1038/sj.npp.1300899 · DOI · Paper page
  160. Yeomans, 2002, Tactile, acoustic and vestibular systems sum to elicit the startle reflex, Neurosci. Biobehav. Rev., 26, 1, 10.1016/S0149-7634(01)00057-4 · DOI · Paper page
  161. Yilmazer-Hanke, 2002, Contribution of amygdala neurons containing peptides and calcium-binding proteins to fear-potentiated startle and exploration-related anxiety in inbred Roman high- and low-avoidance rats, Eur. J. Neurosci., 15, 1206, 10.1046/j.1460-9568.2002.01945.x · DOI
  162. Young, 2004, Effect of comorbid anxiety disorders on the hypothalamic–pituitary–adrenal axis response to a social stressor in major depression, Biol. Psychiatry, 56, 113, 10.1016/j.biopsych.2004.03.017 · DOI · Paper page
  163. Zobel, 2000, Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated, J. Psychiatr. Res., 34, 171, 10.1016/S0022-3956(00)00016-9 · DOI · Paper page
  164. Zorrilla, 2004, The therapeutic potential of CRF1 antagonists for anxiety, Expert Opin. Invest. Drugs, 13, 799, 10.1517/13543784.13.7.799 · DOI · Paper page

Cited by

See all 236

Metadata

Authors
Risbrough, V. B., & Stein, M. B.
Venue
Hormones and Behavior
Publisher
Elsevier BV
Published
2006-11
Volume
50
Issue
4
Pages
550-561
ISSN
0018-506X (ISSN-L)
OpenAlex
W2042431879
Cited by
236
References
41
FWCI
6.57
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.